A new class of radiation devices is emerging that has the potential to transform how cancer is treated through more precise tumour targeting and the adaptation of treatment every time. High-field MR-linac technology integrates the power of state-of-the-art MR imaging with precision radiation technology. It can deliver precisely targeted radiation doses while simultaneously capturing the highest-quality MR images, which will allow clinicians to visualize both tumours and the surrounding healthy tissue at any time during radiation delivery, and adapt the treatment accordingly.
During this webinar, clinical experts share their experience with a novel high-field MR-linac. The speakers are currently utilizing this new technology and present their latest work on the imaging studies that have been undertaken prior to clinical introduction. This work will support the new and rapidly emerging area of MR radiation therapy (MR/RT).
High-field MR-linac devices based on diagnostic-standard MRI technology will offer many avenues for exploring improvements in radiotherapy, such as shorter treatment regimens or targeted adaptation of the treatment in real time. Also, by integrating precision radiation and MRI technologies, high-field MRI capabilities can be optimally explored to help bring personalized cancer care to radiation therapy.
Elekta MR-linac is work in progress and not available for sale.
Susan Lalondrelle, MD, Institute of Cancer Research/Royal Marsden Hospital, London, UK
Uwe Oelfke, PhD, Institute of Cancer Research/Royal Marsden Hospital, London, UK
Moderator: Tami Freeman
Tami Freeman is the medical and biophysics editor of Physics World.